Commonly used preventive therapy for recurrent miscarriage proved ineffective in large trial

(European Society of Human Reproduction and Embryology) An immune response to pregnancy (in which the uterus rejects the embryo or foetus) is said to explain a large number of otherwise 'unexplained' miscarriages. Thus, preventive treatment designed to suppress this immunological rejection during implantation and pregnancy has become a commonly accepted -- albeit innovative - approach to preventing recurrent pregnancy loss.